Boehringer Ingelheim ranks 12 among 20 pharmaceutical companies in the Access-To-Medicine Index for 2021, climbing two places. This was in recognition of its ongoing effort to overcoming barriers to access to healthcare, especially for vulnerable groups and communities in lower-to-middle-income countries. The Access-To-Medicine ranking report acknowledged Boehringer Ingelheim’s investments in R&D areas that are aligned … Continue reading Boehringer Ingelheim Ranks 12 in 2021 Access-To-Medicine Index